focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Result of AGM

27 Jan 2022 16:10

RNS Number : 8984Z
InnovaDerma PLC
27 January 2022
 

 

 LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

("InnovaDerma" or the "Group")

Results of Annual General Meeting

InnovaDerma (LSE: IDP), a leading digitally focused UK beauty brand developer, is pleased to announce that at its Annual General Meeting ("AGM") held earlier today, all resolutions, were duly passed on a poll. 

AGM Resolutions

Resolutions 12 and 13 were proposed as special resolutions. All other resolutions were proposed as ordinary resolutions.  The results of the poll are set out below: 

Issued Share Capital ("ISC")

28,057,825

Votes cast (average across all resolutions)

1,824,040

% of ISC voted (average across all resolutions)

6.5%

 

RESOLUTIONS

Votes For

%

Votes Against

%

Votes Cast

Vote withheld*

% of ISC voted

1. To receive and adopt the annual accounts for the year ended 30 June 2021.

1824195

100%

0

0%

1824195

29919

6.5%

 

 

 

2. To receive and approve the director's remuneration report for the year ended 30 June 2021.

1816581

99.6%

7464

0.4%

1824045

30069

6.5%

 

 

 

3. To approve the Directors' Remuneration Policy

1816581

99.6%

7464

0.4%

1824045

30069

6.5%

 

 

4. To reappoint Crowe UK LLP as auditors of the company.

1816731

99.7%

5861

0.3%

1822592

31522

6.5%

 

 

5. To authorise the directors to fix the remuneration of the auditors.

1824195

100%

0

0%

1824195

29919

6.5%

 

 

6. To reappoint Ross Andrews as a director.

1806314

99.1%

16278

0.9%

1822592

31522

6.5%

 

7. To reappoint Mark Michael Ward as a director.

1818186

100%

0

0%

1818186

35928

6.5%

 

 

8. To reappoint Andrew Dunderdale as a director.

1817314

99.7%

5278

0.3%

1822592

31522

6.5%

 

 

9. To reappoint Blake Hughes as a director.

1812908

99.7%

5278

0.3%

1818186

35928

6.5%

 

10. To reappoint Simon Pyper as a director.

1817314

99.7%

5278

0.3%

1822592

31522

6.5%

 

11. To confer on the Directors authority to allot securities in accordance with Section 551 of the Companies Act 2006.

1809509

99.3%

13083

0.7%

1822592

31522

6.5%

 

 

 

 

12. To confer on the Directors power to allot securities under a disapplication of Section 561 of the Companies Act 2006.

1805103

99.3%

13083

0.7%

1818186

35928

6.5%

 

 

 

 

13. To authorise the Company to make market purchases of its own shares for the purposes of Sections 693 and 701 of the Companies Act 2006.

1811695

98%

36825

2%

1848520

5594

6.6%

 

 

 

 

* A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes 'For' or 'Against' a resolution.

The full text of all the resolutions can be found in the Notice of Annual General Meeting which is available for viewing from the Group's website at:  https://www.innovaderma.com/company-publications

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Further enquiries

InnovaDerma

Blake Hughes

 

c/o TB Cardew

finncap Ltd

Geoff Nash/Kate Bannatyne

Alice Lane - Corporate Broking

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew

Shan Shan Willenbrock/

+ 44 (0)7775 848537

Olivia Rosser

+ 44 (0)7552 864250

innovaDerma@tbcardew.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGPPUMUGUPPGQM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.